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Objectives. This study sought o identify risk factors for both 
late observed and late "excess" mortality after aortic valve 
replacement and to examine the causes of late mortality. 
Background. Because operative mortality after aortic valve 
replacement is very low, the timing of surgical intervention should 
focus on maximizing long-term survival. However, to judge the 
effect of valve replacement on long-term survival in an elderly 
population, it is important to separate mortality resulting from 
extraneous causes (background mortality) from disease.related 
mortality (excess mortality). Background mortality can be esti- 
mated by calculating expected mortality on the basis of age and 
gender. 
Methods. From 1966 to 1986, 643 patients (mean age 59.6 years, 
138 [21%] >70 years old) underwent aortic valve replacement, 
129 of whom also underwent coronary bypass grafting; 594 
patients survived >30 days after the procedure. The overall 
operative mortality rate for isolated aortic valve replacement 
decreased over time from 25.5% (1966 to 1972) to 2.6% (1980 to 
1986). Cumulative total follow.up after discharge was 3,603 
patient-years. Multivariate analysis was performed for both ob- 
served and excess mortality. 
Results. Risk factors for both observed and excess mortality 
were previous myocardial infarction, coronary artery disease, 
heart failure and atrial fibrillation. Although age >70 years was a 
risk factor for observed mortality (hazard rate ratio [HRR] 2.4, 
95% confidence interval [CI] 1.6 to 3.7), it was not a risk factor for 
excess mortality. In contrast, isolated aortic regurgitation was an 
important risk factor for excess mortality only (HRR 3.8, 95% CI 
1.3 to 11.2). Late mortality was valve related in 22% of patients, 
including sudden death in 7% and cerebral vascular accidents in 
7%. Congestive heart failure was an important cause of death 
(21%) irrespective of the time elapsed since aortic valve replace- 
ment. In patients with aortic regurgitation, congestive heart 
failure was the main cause of death (38%); in patients with aortic 
regurgitation and preoperative h art failure or severe left ventric- 
ular dysfunction, heart failure was the cause of death in 44% and 
63%, respectively. 
Conclusions. Analysis of excess mortality revealed that older 
age in itself is not a risk factor for late mortality after aortic valve 
replacement. Aortic regurgitation carries a high risk, probably 
associated with left ventricular dysfunction at the time of opera- 
tion. Earlier operation may be warranted in such patients. 
(J Am CoU Cardio11995;26:1280-6) 
Because operative mortality related to aortic valve replace- 
ment is now yew low, the decision to operate should aim at 
timing the intervention to maximize long-term survival. How- 
ever, this timing can be determined only on the basis of clinical 
studies that randomize the timing of the operation. Neverthe- 
less, some insight can be gained by identifying mortality risk 
factors that separate patients with a better prognosis from 
those with a poorer prognosis. 
Because aortic valve replacement is usually performed in 
elderly patients, it is important to distinguish between mortal- 
ity from extraneous causes ("background" mortality) and 
From the Departments of Cardiology, Cardiopulmonary Surge~ and Clini- 
cal Epidemiology and Biostatistics. Academic Medical Center. University of 
Amsterdam, The Netherlands. 
Manuscript received July 13, 1994: revised manuscript received May 2~. 
1995, accepted June 2, 1995. 
Address for correspondence: Dr. Hans A. Verheul. Department ofCardiol- 
ogy, Academic Medical Center, F4-111k Meibergdreef t).1105 AZ Amsterdam, 
The Netherlands. 
disease-related mortality ("excess" mortality). Causes of death 
can be classified as disease related or not, and background 
mortality can be estimated from expected mortality. When 
expected mortality is subtracted from observed mortality, the 
result is excess mortality. In recent years, several long-term 
survival studies (1-3) from the Scandinavian countries have 
indicated the importance of comparing the observed survival 
after aortic valve replacement with the expected survival in a 
reference group matched with the study cohort for age, gender 
and calendar time at operation (1-3). 
In the present historical cohort study, we report our expe- 
rience with aortic valve replacement from 1966 to 1986. The 
objective of the present study was to identify risk factors for 
both observed and excess late mortality. 
Determining background mortality isproblematic inthat by 
comparing the dynamic study cohort with a static reference 
group drawn from the general population, the heterogeneity of 
the distribution of observed mortality in younger and elderly 
patients may result in an increased estimate of background 
©1995 by the American College of Cardi.d~g> 0735-1097/95/$9.50 
0735-1097(95)00303-L 
JACC Vol. 26, No. 5 VERHEUL ET AL. 1281 
November 1, 1995:1280 6 EXCESS MORTALITY AFTER AORTIC VALVE REPLACEMENT 
Table 1. Clinical Characteristics According to Type of Valve Dysfunction 
AS or 
AS/AR AR All 
(n - 4%) (n 147) (n - 643) 
Mean (_+SD) age (yr) 61.5 + 11.6 53.2 _+ 13.5 59.6 _+ 12.6 
Age ->70 yr 126 (25%) 12 (8%) 138 (21%) 
Men 308 (62%) 102 (69%) 410 (64%) 
NYHA functional class I II/IV 381 (77%) 125 (85%) 506 (79%) 
Congestive heart failure 111 (22%) 54 (37%) 165 (26%) 
Atrial fibrillation 37 (8%) 13 (9%) 50 (8%) 
Active endocarditis 1 23 (16%) 24 (4%) 
Corona~, arte~' disease 119 (24%) 37 (25%) 156 (24%) 
Mitral valve regurgitation 90 (18%) 28 (19%) 118 (18%) 
Severely impaired LV function 66 ( 13c'~ ) 24 (16%) 90 (14%) 
30-day mortality rate after isolated AVR 
1966-1972 28.(/~ 15.4% 25.0% 
1980-1986 2.4¢~ 3.7% 2.6% 
Unless otherwise indicated, data presented are number (%) of patients. AR = aortic regurgitation; AVR = aortic 
valve replacement: AS = aortic stenosis; LV - left ventricular: NYHA - New York Heart Association. 
mortality (4). To overcome this bias and to improve survival 
analysis, we applied rate adjustment when calculating back- 
ground mortality, that is, we maintained age, gender and 
calendar time of the reference group identical at all times to 
those of each patient still alive and under observation (4). 
Methods  
Study group. The study group included 643 patients (>20 
years old) who underwent aortic valve replacement during 
1966 through 1986, of whom 129 (21)%) also underwent bypass 
surgery. Patients who had additional cardiac surgical proce- 
dures were excluded. The mean age was 59.6 years (SD 12.6, 
maximal age 85.7); 138 patients (21%) were >70 years old, and 
410 were men (64%). 
Angina pectoris was the main indication for operation in 
32% of patients without and 64~ with coronary bypass ur- 
gery. Dyspnea was the clinical indication in 44.3% of patients 
and syncope in 7.3%. An emergency operation because of a life 
threatening condition was required in 6% of patients, of whom 
24 had active infective ndocarditis (4C/c). Aortic stenosis was 
diagnosed in 26% of patients, isolated aortic regurgitation i  
23% and mixed aortic stenosis and regurgitation i  51%. The 
clinical characteristics of the patients are presented inTable 1. 
Clinical and catheterization data. All clinical documenta- 
tion, catheterization data and correspondence w re collected 
by retrospective chart review and processed in a structured 
data base. Preoperative symptoms were classified according to 
New York Heart Association functional criteria. Prior myocar- 
dial infarction was recorded in cases of enzyme level and 
electrocardiographic (ECG) verification. Congestive heart fail- 
ure was defined as pulmonary edema or pulmonary vascular 
congestion, both auscultatory and radiographic, during the 
year before operation. Atrial fibrillation on the ECG and 
cardiomegaly (cardiac thoracic ratio ->50%) on a standard 
chest radiograph were recorded. Endocarditis was classified 
using strict criteria (5), and the active phase was defined as <6 
weeks of medical treatment. 
Left heart catheterization was performed in 556 patients 
(86%); the remaining 87 patients were examined by Doppler 
echocardiography or, if they were too ill to sustain cardiac 
catheterization, by physical examination and two-dimensional 
echocardiography (before 1986). Aortic valve lesions were 
classified as stenotic (peak to peak gradient ->30 mm Hg and 
regurgitation grade ---2/4), isolated regurgitation (peak to peak 
gradient <30 mm Hg and regurgitation grade ->3/4) and mixed 
(peak to peak gradient ->30 mm Hg and regurgitation grade 
->3/4). Left ventricular function was evaluated qualitatively by 
examination of the 30 ° right anterior oblique left ventriculo- 
gram and classified into categories of normal function and 
moderate or severe impairment. Moderate impairment was 
defined as dyskinesia of two segments and severe impairment as 
dyskinesia of more than two segments. Coronary artery disease, 
defined as lumen narrowing >50%, was present in 156 patients 
(24%), of whom 76 had one-vessel disease (12%), 47 had 
two-vessel disease (7%), and 33 had three-vessel disease (5%). 
Unavailability of information was due to limited clinical 
registration i the early period, incomplete catheterization (no 
coronary angiography because of young age or endocarditis; no 
transvalvular g adient because of an inability to access the left 
ventricle) or loss of information. 
Surgical technique. Two methods of myocardial preserva- 
tion were used: before 1978, continuous selective perfusion of 
the coronary arteries combined with local and general hypo- 
thermia, and beginning in 1978, cardioplegia by anterograde 
perfusion with St. Thomas's Hospital's olution into the coro- 
nary arteries. After excision of the valve and, when necessary, 
thorough annular debridement of calcium, the largest prosthe- 
sis that could be fitted into the annulus was implanted using 
interrupted everting mattress utures. Before 1973, Starr- 
Edwards prostheses were used (n = 70 [11% of the study 
group]). These were followed by use of Bj6rk-Shiley prostheses 
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until 1984 (n - 292 [45%]). After 1984, the Medtronic-Hall 
valve became the principal choice of prosthesis (n = 149 
[23%]). St. Jude Medical prostheses were used in cases of a 
small orifice (n = 21 [3%]). Bioprostheses were nearly all 
Carpentier-Edwards (n = 86 [13%]) and were used since 1980 
in some patients >70 years old and when anticoagulation was 
contraindicated. Infrequently, other valve prostheses were 
implanted (4%). 
All patients with mechanical prostheses received lifelong 
anticoagulation (target international normalized ratio 3 to 4.5); 
patients with bioprostheses received anticoagulation within the 
first 3 months of implantation. Since 1976, concomitant coronary 
artery bypass grafting was performed if significant lesions were 
present in the major branches. The average number of grafts was 
1.6, and the average number of distal anastomoses was 2.1/ 
patient. The operative mortality rate for isolated aortic valve 
replacement decreased from 25.5% in the period from 1966 to 
1972 to 2.6% from 1980 to 1986. The operative mortality rate 
in patients <70 years old and without active infective ndocar- 
ditis was 0.6% for combined aortic stenosis and regurgitation 
and 0% for isolated aortic regurgitation (1980 to 1986). The 
overall operative mortality rate for patients who underwent 
concomitant coronary artery bypass grafting was 13.9%. 
Follow-up data and outcome events. Death after 30 days 
was classified as late mortality. A collective review of all 
evidence, including clinical records, postmortem examination 
and information from the Census Bureau (Central Bureau of 
Statistics), if present, was used to classify deaths into the 
following categories: surgical death, valve-related eath, 
cardiac-related death, other causes and "circumstances un- 
known" (6). Surgical death was caused by intractable bleeding, 
major infection or sepsis, respiratory failure or multiorgan 
failure. Valve-related mortalit), was defined as death caused by 
structural deterioration (leaflet tear or stress fracture), non- 
structural dysfunction (paravalvular leakage, entrapment), 
thromboembolism, anticoagulant-related bl eding, prosthetic 
valve endocarditis (death within 30 days after reoperation), 
sudden unexpected and unexplained death or fatal cerebrovas- 
cular accident. Cardiac' death was defined as death due to 
myocardial infarction, heart failure or secondary cardiac ar- 
rhythmias. Other causes of death were mainly from malignancy 
and trauma. If absolutely no information on causes or circum- 
stances of death was available (e.g., patients who emigrated), 
patients were classified as "circumstances unknown." 
Data on clinical course and functional status at the end of 
follow-up of hospital survivors were collected by one of us 
(B.J.B.) from the outpatient clinical records. If this approach 
was not feasible, a questionnaire was answered by the attend- 
ing cardiologist. The end of the follow-up period was January 
1988. 
Statistical analysis. Continuous variables are reported as 
mean value _+SD. Chi-square analysis was used to test differ- 
ences between categoric variables. The Student t test was used 
for differences between continuous variables. 
Cumulative survival was estimated by the Kaplan-Meier 
method (7). Potential risk factors were dichotomized into two 
categories: an index group, for which the risk was assumed to 
be increased, and a reference group that consisted of all other 
cases, including the unclassified. Factors studied were age, 
gender, preoperative functional c ass (class III or IV vs. other), 
previous myocardial infarction, congestive heart failure, active 
infective endocarditis, atrial fibrillation, cardiomegaly, coro- 
nary artery disease, aortic regurgitation (isolated regurgitation 
vs. stenosis/mixed lesion), mitral valve regurgitation, left ven- 
tricular function (severe impaired vs. normal/moderately im- 
paired), valve size (-<23 vs. >23) and prosthesis type (biopros- 
thesis vs. mechanical prosthesis). 
The Cox proportional hazards model was used to examine 
the impact of covariates (risk factors or determinants) on 
observed late mortality. "Hazard" was defined as the proba- 
bility of dying within a short interval, as a function of time, 
given that the patient survived until the beginning of the 
interval. The ratio of the mortality hazard in the index group to 
that in the reference group is the hazard rate ratio. 
Expected survival and excess mortality were estimated as 
follows: Background mortality was estimated by extracting 
from life-table data from the Dutch Census Bureau (Centraal 
Bureau voor de Statistiek), for each day that each patient was 
observed, the mortality fraction for that same day of a coun- 
terpart from the general population matched with the patient 
for age, gender and year of observation. Thus, by this method, 
whenever a patient was lost to follow-up, either by death or by 
end of the study, we withdrew his or her referent from the 
reference group. Together, these referents formed the refer- 
ence group. Finding the mean mortality per day of these 
referents, a procedure known as rate adjustment, ensures that 
the reference parameters remain comparable at all times 
between the patient group and the reference group (4). This 
adjusted mortality rate indicates the probable mortality rates 
for the patient group if they had the same rates as those of the 
normal population. When this mortality fraction is dealt with 
analogously to the instantaneous mortality that is calculated 
after the death of each patient by the Kaplan-Meier method 
(7), it leads to the expected survival curve. Excess mortality is the 
difference between observed and expected survival. The hazard 
was separated into an expected (background) component and 
an excess component. Risk factors for excess mortality were 
identified through Poisson regression, as described by Hakuli- 
nen and Abeywickrama (8). 
To control for overall improvement of surgical perfor- 
mance, the analysis was first stratified for date of operation; the 
study period was divided in two intervals (early experience 
[1966 to 1976] and current experience [1977 to 1986]). 
Cox proportional hazard regression was performed with the 
BMDP package (9). Poisson regression of excess mortality was 
performed with the GLIM package (10). 
Resu l ts  
Late mortality and long-term survival. Of the 643 patients, 
49 did not survive >30 days. Follow-up after discharge was 
complete in 583 (98%) of the remaining 594 patients, a 
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Figure 1. Causes of death after discharge for 594 patients according to
follow-up time. Solid line = number of patients at risk; columns = 
mortality. 
cumulative total of 3,603 patient-years. Mean follow-up time 
was 73 months. In total, 135 (late) deaths occurred. 
Late mortality was valve related in 22% of patients and 
included all sudden and unexplained eaths (7%) and all 
cerebrovascular accidents (7%). Cardiac death was responsible 
for 34% of late mortality (mostly congestive heart failure 
[21%]), other causes for 36%, and no information was avail- 
able for 8%. 
Figure 1 shows the causes of death according to follow-up 
time. Valve-related deaths and deaths due to congestive heart 
failure and other cardiac auses remained essentially constant 
over time. Of 29 patients who died at age <50 years, 6 (21%) 
died of valve-related causes and 9 (31%) of congestive heart 
failure. Congestive heart failure was the main cause of death in 
patients with aortic regurgitation (38%), whereas in patients 
with aortic stenosis, this was the cause in less than half (14%). 
In patients with aortic regurgitation who had preoperative 
congestive heart failure or severe left ventricular dysfunction, 
death was due to congestive heart failure in 44% and 63%, 
respectively. 
The overall cumulative 5-, 10-, 15- and 20-year survival rate 
was estimated to be 83%, 67%, 55% and 36%, respectively. 
For patients <70 years old undergoing isolated aortic valve 
replacement, the cumulative 5-, 10- and 15-year survival rate 
was 87%, 75% and 61%, respectively; after combined valve 
replacement and coronary artery bypass grafting, the 5- and 
10-year survival rate was 83% and 49%, respectively. For 
patients >-70 years old undergoing isolated valve replacement, 
the cumulative 5- and 10-year survival rate was 76% and 41%, 
respectively. After combined valve replacement and coronary 
artery bypass grafting, the 5-year survival rate was 55%. 
A first analysis of the association between potential risk 
factors for late mortality, stratified according to the timing of 
operation (before and after 1977), revealed no significant 
differences between the two periods. Although there were 
substantial differences in patient characteristics between the 
two subgroups, the direction and magnitude of the risk factors 
were the same in the precardioplegic era. Therefore, only the 
results of the pooled analysis, combining the two subgroups, 
arc reported here. 
Multivariate analysis of long-term survival (observed mor- 
tality) showed an increased risk in elderly patients (hazard rate 
ratio [HRR] 2.4, 95% confidence interval [CI] 1.6 to 3.7), 
patients with documented myocardial infarction (HRR 1.8, 
95% CI 1.1 to 3.1) or coronary artery disease (HRR 2.1, 95% 
CI 1.4 to 3.1) and patients with heart failure (HRR 1.7, 95% CI 
1.1 to 2.5). Patients with atrial fibrillation showed the highest 
risk (HRR 2.6, 95% CI 1.5 to 4.4). 
Expected survival and excess mortality. Expected 5-, 10- 
and 15-year survival rate was 89%, 80% and 72%, respectively. 
Figures 2 and 3 show observed and expected survival in our 
Figure 2. Survival after aortic valve replacement. 
Cumulative observed survival and expected (exp) 
survival after discharge for 594 patients according to
age (<70 years old, n = 469, 5- and 10-year observed 
survival rates 86 + 2% and 72 _+ 3%, respectively; 
->70 years old, n = 125, 5- and ]0-year observed 
survival rates 70 -+ 5% and 39 _~ 11 c& respectively). 
% pat ients  
t°° T -, T 
60 j ~ , c 
| ~ ~ 70 yr  exp ~ ~_ 
I _ __  ' " .~ 
! I _ 70 yr exp  
I 
! . . . . .  
I 
2o~ 
469 258 102 
125 36  
0 I . . . . .  j 
0 5 10 
years after operation 
15 
1284 VERHEUL ET AL. JACC Vol. 26, No. 5 
EXCESS MORTALITY AH'ER AOR'IIC VALVE REPLACEMENT November 1, 1995:1280-6 
% patients 
1 0 0 ( ~  
8O 
6O 
4O 
2O 
135 
459 
0 
0 
O AR 
Q AR exp 
AS+AS/R 
~- AS÷AS/R exp 
80 30 
214 72 
5 10 
years after operat ion  
9 
16 
15 
Figure 3. Survival after aortic valve replacement. Cu- 
mulative observed survival nd expected (exp) survival 
after discharge for 594 patients according to type of 
valve dysfunction (isolated aortic regurgitation [AR], 
n = 135, 5- and 10-year observed survival rates 81 _+ 
3% and 65 _+ 5%, respectively; aortic stenosis [AS]/ 
mixed lesion, n= 459, 5- and 10-year observed survival 
rates 83 -- 2% and 68 -+ 3%, respectively). 
study group stratified according to age (cutoff point 70 years) 
(Fig. 2) and valve dysfunction (isolated aortic regurgitation vs. 
aortic stenosis or mixed lesion) (Fig. 3). 
For excess mortality as well, no significant differences inrisk 
factors could be found between the subgroups operated on in 
the early period (1966 to 1976) and the more recent period 
(1977 to 1986). 
Multivariate analysis of excess mortality showed that pa- 
tients with atrial fibrillation were at highest risk (excess mor- 
tality hazard rate ratio [EHRR] 4.3, 95% CI 1.4 to 13.2), 
followed by patients with aortic regurgitation (EHRR 3.8, 
95% CI 1.3 to 11.2), patients with a previous myocardial 
infarction (EHRR 3.6, 95% CI 1.3 to 11.2) and coronary 
arjtery disease (EHRR 2.9, 95% CI 1 to 8.3) and patients with 
heart failure (EHRR 2.7, 95% CI 1.05 to 7.1). 
Discuss ion 
Timing of aortic valve replacement. Published reports 
(3,11-13) are inconclusive regarding optimal timing of aortic 
valve replacement. Management of valvular heart disease is 
based mainly on surgical outcome, valve-related morbidity, 
residual heart disease and long-term survival. The present 
study, based on 20 years of experience in 643 patients under- 
going aortic valve replacement (combined with coronary artery 
bypass surgery in 129 patients), was undertaken to identify 
determinants of differences in long-term survival and causes of 
death, which may guide risk assessment ofpatients with aortic 
valve disease. 
An evident and strong decrease in operative mortality after 
aortic valve replacement has been reported (3,11,13-17), 
which must be attributed to better myocardial preservation 
(cold cardioplegia since 1978), shorter extracorporeal circula- 
tion time and overall improved surgical technique. Our expe- 
rience shows a similar strong decrease in operative mortality, 
although the patients operated on later were much older and 
more often had coronary artery disease and preoperative 
patient status, as reflected by an unchanged functional class. 
Between 1980 and 1986, operative mortality for isolated aortic 
valve replacement (without coronary artery bypass urgery) in 
patients <70 years old and without active infective ndocardi- 
tis was 0.6% for isolated aortic stenosis or combined stenosis 
and regurgitation a d 0% in isolated aortic regurgitation. 
Mortality. After patients receive a prosthetic valve, new 
potential causes of death prevail, such as prosthetic valve 
dysfunction, anticoagulant-related bleeding and thromboem- 
bolism. The incidence of valve-related death is highest in the 
first 3 months after operation. Thereafter, it decreases to a 
yearly incidence of 0.7% to 1.0% and seems to be mainly 
linked to patient-related variables (18-21). It is often stated 
that in these patients, native valve disease is exchanged for 
prosthetic valve disease and that the operation should be 
postponed until (marked) symptoms appear, despite medical 
treatment orwhether asymptomatic patients develop progres- 
sive cardiomegaly (11,12,22-24). This management strategy, 
which was also applied in the present study, is based on our 
knowledge of the natural history of aortic valve disease and on 
the results of studies reporting the long-term survival after 
aortic valve replacement. 
In our series, the overall cumulative 5- and 10-year survival 
rate after hospital discharge after aortic valve replacement was 
83% and 67%, respectively, which is in accord with the findings 
of others (1-3,13-15,17,24). Although an evident decrease in 
operative mortality is shown and prosthetic valve design im- 
proved, it is striking that the 5- and 10-year survival rate 
remained unchanged in our series as well as in others (25). This 
result is probably related to postponement of aortic valve 
replacement until life expectancy with native aortic valve 
disease is lower than that after operation and is based on 
studies that consider only observed long-term survival. 
Survival studies after aortic valve replacement often de- 
scribe an elderly patient population with an extended observa- 
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tion period. This dynamic study population is then, in nearly all 
survival studies, compared with a static reference group 
(matched for age, gender and calendar time) drawn from the 
general population at the time of valve replacement, which 
tends to increase the estimate of background mortality. This 
overestimation of background mortality partly obscures the 
excess mortality that is disease related. To overcome this bias, 
we applied rate adjustment to the calculation of background 
mortality. 
Analysis of excess mortality. To our knowledge, this is the 
first study to report a multivariate analysis of excess mortality 
after valve replacement. This multivariate analysis of excess 
mortality demonstrated that older age (->70 years), which is a 
risk factor for observed mortality, is not a determinant of 
excess mortality. Background mortality becomes increasingly 
important in patients ->70 years old. Five risk factors for excess 
mortality were identified: myocardial infarction, coronary ar- 
tery disease, atrial fibrillation, congestive heart failure and 
aortic regurgitation. Aortic regurgitation, which is not a risk 
factor for observed mortality (in many young patients) is a 
strong risk factor for excess mortality (fourfold increase). This 
finding was obscured in the traditional analysis of observed 
long-term survival. Noteworthy is that early experience (1966 
to 1976), the precardioplegic era, is not a risk factor for excess 
mortality. Although many improvements in anesthetic and 
surgical techniques have decreased operative mortality, survi- 
vors operated on in the early period are not at increased risk 
for late death compared with those operated on in the current 
period. 
Valve-related eath is not the main cause of death in 
patient groups with at least one risk factor. Moreover, we used 
the guidelines of the Society of Thoracic Surgery to define 
valve-related mortality, which probably results in an overesti- 
mation (22%) when all fatal strokes (7%) and all sudden and 
unexplained deaths (7%) are included. However, the incidence 
of fatal strokes also strongly increases in elderly patients 
without valvular heart disease (26). Furthermore, not all of the 
sudden and unexplained eaths (7%) may have been valve 
related. In a study (27) on the incidence of complications in 
patients with Bjork-Shiley valves with a very high necropsy rate 
(77%), it was found that of all sudden and unexplained eaths 
only 18% were due to valve-related complications. 
During long-term follow-up, congestive heart failure was a 
major cause of death (21%), irrespective of the time that had 
elapsed since aortic valve replacement. Subgroup analysis 
revealed that patients with aortic regurgitation had the highest 
mortality rate owing to congestive heart failure (38%); this 
figure was even higher in patients with preoperative congestive 
heart failure (44%) or severe impaired left ventricular function 
(63%). 
Limitations of the study. Expected survival curves and 
excess mortality based on mortality data derived from the 
general population must be interpreted cautiously. Patient 
groups are not random samples from the general population 
that differ only by disease entity under study. Mortality is 
determined by many factors, few of which are taken into 
account when matching for demographic variables and other 
important indexes of survival, such as race or socioeconomic 
class, which are rarely available. In particular, patients elected 
for cardiac surgery tend not to have serious comorbidity, which 
could be reflected in the mortality pattern. Differences in the 
distribution of such variables can bias any comparison. 
Conclusions. In our opinion, management of valvular 
heart disease should be guided primarily by an analysis of 
excess mortality rather than observed mortality and causes of 
late mortality. In the present cohort, older age itself was not a 
risk factor for excess mortality. We believe that elderly patients 
should not be denied aortic valve replacement on the basis of 
age alone. Although aortic regurgitation was not a risk factor 
for observed mortality, it was a strong risk factor for excess 
mortality. In these patients, congestive heart failure was the 
principal cause of death, especially when congestive heart 
failure or severe impaired left ventricular function was present 
preoperatively. The present evidence may warrant earlier 
operation in patients with aortic regurgitation, before ad- 
vanced left ventricular dysfunction and possible irreversible 
injury occur. 
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